Pfizer’s Epogen/Procrit biosimilar wins US backing

26th May 2017 Uncategorised 0

Pfizer’s biosimilar of Amgen’s epoetin alfa (Epogen/Procrit) has won backing in the US for approval across all proposed indications.

More: Pfizer’s Epogen/Procrit biosimilar wins US backing
Source: News